Abstract
Two patients with muscle weakness caused by amyloid myopathy are described. Characteristic features such as pseudohypertrophy and abnormal firmness, and tumours of muscles were absent. It is suggested that muscle weakness in amyloid myopathy is caused by layers of amyloid covering muscle fibres. In middle aged or elderly patients with proximal muscle weakness the diagnosis of amyloid myopathy should be considered.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arvidson B. Evidence for vesicular transport of horseradish peroxidase across endoneurial vessels of the sciatic nerve in normal mice. Acta Neuropathol. 1984;64(1):1–5. doi: 10.1007/BF00695598. [DOI] [PubMed] [Google Scholar]
- Bruni J., Bilbao J. M., Pritzker P. H. Myopathy associated with amyloid angiopathy. Can J Neurol Sci. 1977 Feb;4(1):77–80. [PubMed] [Google Scholar]
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 26-1986. A 62-year-old man with progressive polyneuropathy. N Engl J Med. 1986 Jul 3;315(1):45–55. doi: 10.1056/NEJM198607033150108. [DOI] [PubMed] [Google Scholar]
- Cohen A. S., Gross E., Shirahama T. The light and electron microscopic autoradiographic demonstration of local amyloid formation in spleen explants. Am J Pathol. 1965 Dec;47(6):1079–1111. [PMC free article] [PubMed] [Google Scholar]
- Dalakas M. C., Cunningham G. Characterization of amyloid deposits in biopsies of 15 with "sporadic" (non-familial or plasma cell dyscrasia amyloid polyneuropathy. Acta Neuropathol. 1986;69(1-2):66–72. doi: 10.1007/BF00687040. [DOI] [PubMed] [Google Scholar]
- FISHER J. H. Primary amyloidosis. Can Med Assoc J. 1958 Feb 15;78(4):264–266. [PMC free article] [PubMed] [Google Scholar]
- Kyle R. A., Greipp P. R. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc. 1983 Oct;58(10):665–683. [PubMed] [Google Scholar]
- Lange R. K. Primary amyloidosis of muscle. South Med J. 1970 Mar;63(3):321–323. doi: 10.1097/00007611-197003000-00018. [DOI] [PubMed] [Google Scholar]
- Martin J. J., Van Bogaert L., Van Damme J., Peremans J. Sur une pseudo-myopathie ligneuse généralisée par amyloïdose primaire endomysio-vasculaire. J Neurol Sci. 1970 Aug;11(2):147–166. doi: 10.1016/0022-510x(70)90125-5. [DOI] [PubMed] [Google Scholar]
- Ringel S. P., Claman H. N. Amyloid-associated muscle pseudohypertrophy. Arch Neurol. 1982 Jul;39(7):413–417. doi: 10.1001/archneur.1982.00510190031009. [DOI] [PubMed] [Google Scholar]
- Smith T. J., Kyle R. A., Lie J. T. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc. 1984 Aug;59(8):547–555. doi: 10.1016/s0025-6196(12)61493-1. [DOI] [PubMed] [Google Scholar]
- Whitaker J. N., Hashimoto K., Quinones M. Skeletal muscle pseudohypertrophy in primary amyloidosis. Neurology. 1977 Jan;27(1):47–54. doi: 10.1212/wnl.27.1.47. [DOI] [PubMed] [Google Scholar]